Categorized | Stock Profiles

PLPL (Plandai Biotechnology)

Share Button

plpl logoPlandai Biotechnology (PLPL) is the developer of highly bioavailable, phytonutrient rich extracts that are being utilized to deliver a new family of safe, cost efficient drugs to treat a variety of diseases and conditions.

The use of natural cures has found its way into modern pharmacology however, many of the most promising natural cures suffer from the body’s inability to absorb high concentrations of the necessary nutrients, also called low bioavailability.

With over 10 years of research in live plant extracts, PLPL is addressing this issue by harvesting fresh plants through a patented extraction process technology, known as Phytofare, which allows the molecules to be “unzipped” and rearrange the released nutrients to increase its absorption rate.Controlling every part of the production process, PLP currently operates on 8,500 acres in South Africa that grows the specific necessary raw materials and produces the patented Phytofare extracts in-house to guarantee the continuity of supply as well as quality control

Resulting from the company’s ability to control every aspect of production, PLPL has proven to improve the bioavailability of its plants 60 – 80%. Currently, the company’s primary extract is one of the most researched agents in the natural botanical sector, the green tea galletecatechin extract, which has over five hundred research studies that this specific extract delivers benefits in treating diabetes 1 and 2, treating high blood pressure, lowering blood cholesterol, relieving symptoms of certain cancers and malaria, weight loss, and anti-aging. Marketed as PhytofareCatechin Complex or “ph2”, PLPL’s proprietary product can be diversely appliedto the Food and Beverage, Cosmecuetical, Wellness, Nutraceutical, Anti-aging, and Pharmaceutical markets.

Furthermore, the company’s Phytofare technology is currently Marketed Globally with Multiple Agreements in Three Continents who have selected PLPL’sgreen tea catechin based Phytofareingredient as the Base of Future Products including the Key Ingredient in a New Fat Burner Product.


Market Outlook:

  • The green tea leaf contains large amounts of polyphenols, such as flavonoids and catechin, which function as antioxidants for the body.
  • Studies have proven green tea has increased fat burning and boosts the metabolic rate.
  • The Global Weight Loss and Weight Management is estimated to reach $206.4 billion by 2019.
  • The Global Nutraceutical market was valued at $165.65 billion in 2014 and is expected to exceed $278 billion by 2021.
  • According to Transparency Market Research, the market will be propelled by soaring demands for functional food and beverages.
  • The global Cosmeceutical Market is estimated to be worth $650 billion by 2020.
  • Global Pharmaceutical sales are predicted to reach $1.3 trillion by 2018.


Recent News:

  • PLPL has Received its Initial Order from a leading developer of high quality nutraceutical and food supplement company South Africa who will use PLPL’sPhytofareCatechin Complex as the base of their new product.
  • The company has relocated its sales office in London, England to accommodate the growing demand for its product and maintain its operations in North America, Europe, and South Africa.

This post was written by:

- who has written 203 posts on StockRockandRoll.

Contact the author

Comments are closed.

© 2021 MJ Capital, LLC | All rights reserved